News and blogs
23 results found.
Blood Cancer UK funded trial shows survival gain, as experts say drug could be repurposed as new treatment standard for rare blood cancer
A new UK trial has found that an oral treatment called ASTX727, could help people with certain rare blood cancers to live longer.
Blood cancer charity says clinical trials report must be a ‘wake-up call' for government and NHS leader
A new report from the Association of the British Pharmaceutical Industry (ABPI) shows that far fewer people in the UK are being recruited into commercial clinical trials.
NHS patients in Scotland to benefit from new blood cancer drug
People with myeloma in Scotland will now be able to access the drug belantamab mafodotin (Blenrep) in combination with bortezomib and dexamethasone (BorDex), following new guidance from the Scottish Medicines Consortium (SMC).
Survival in people with myeloma nearly doubles since 2005
People diagnosed the blood cancer - myeloma - are now living nearly twice as long on average as they were in 2005.
Clinical trial boost with app upgrade
Blood Cancer UK react to the news that the NHS app will now allow people to sign up to clinical trials.
How are clinical trials going to help beat blood cancer in a generation?
On clinical trials day we want to celebrate the vital role clinical trials play in improving survival for people with blood cancer. Read more about how we are supporting clinical trials.
Our response to the Government's plan for UK commercial clinical trials
Refreshing clinical trials activity must benefit people with blood cancer across the UK.
Clinical trials can give people with blood cancer hope
Rachel contacted the Clinical Trials Support Service to find out whether she could potentially take part in a clinical trial and contribute to blood cancer research.
Blood Cancer UK have renewed their partnership with RareCan
Blood Cancer UK have renewed their partnership with RareCan, a digital health company. This could give people an opportunity to help researchers.
A new dawn for clinical trials
A new dawn for clinical trials to get us to a place where no lives are lost to blood cancer
Read Ed's story of being diagnosed with CLL
Ed shares his story of how our Clinical Trials Support Service helped support him through his diagnosis of CLL
My journey on a clinical trial
In this blog, James, who is living with chronic lymphocytic leukaemia, tells us about his journey with blood cancer, and discusses what research means to him.
Blood cancer drug ruxolitinib gives better outcomes than those on best-available existing medication
The drug, ruxolitinib, has been found to be better at treating the blood cancer - polycythaemia vera (PV) than the best currently available treatment.
Shibu's story - taking part in an AML clinical trial
Read Shibu's experience of being diagnosed with acute lymphoblastic leukaemia (AML), and taking part in a clinical trial after failing to find a bone marrow donor.
Supporting people with blood cancer to make decisions around clinical trials
Find out how Millie, an Advanced Nurse Practitioner, helps people with blood cancer take decisions on blood cancer clinical trials.
I put my symptoms down to being pregnant, but it was actually blood cancer.
Read Jemma's story about how her Hodgkin lymphoma symptoms were mistaken as side effects of being pregnant.
Blood cancer clinical trials - Everything you didn't know you needed to know
Read Professor Andrew Pettitt's piece on blood cancer clinical trials, where he explains the benefits, concerns and availability of clinical trials to people with blood cancer..
How we're going to make sure everyone is included in our clinical trials
Discover how Blood Cancer UK recruits people to take part in their clinical trials.
I felt like I'd hit the jackpot: My experiences on a clinical trial
Learn more about Nicky's experience of taking part in a blood cancer clinical trial to treat chronic lymphocytic leukaemia (CLL) .
Deciding to take part in a chronic lymphocytic leukaemia (CLL) clinical trial - David's story
Read how the progression of David's CLL was reversed by taking ibrutinib as part of a blood cancer clinical trial.
